NEWS
Return
to the home page http://www.imor.org
Retutn
to the english home page http://www.imor.org/index_ang.htm
Consult
the news in English contenido3_ang.htm
Consultar la web en español http://www.imor.org
Consultar las noticias en
español contenido3_cast.htm
Consultar la web en català http://www.imor.org/index_cat.htm
Tornar a la pagina principal de
noticies en català contenido3_cat.htm
Return
to the home page ../index.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, presents a revolutionary
treatment for age related wet macular degeneration (AMD). The event was hosted by Professors Dr. Borja Corcóstegui, Director of the
Ocular Microsurgery Institute (IMO) in Barcelona and Dr Benjamin Guix Melcior,
Director of the IMOR Foundation, Medical Institute for Radiotherapy and
Oncology of Barcelona, Spain, who
are serving as a principle investigator for the NeoVista sponsored CABERNET
clinical study. Also on the program were John N. Hendrick, President and CEO of
NeoVista; Dr. Eugene de Juan, vice chairman of ForSight Labs and co-inventor of
the NeoVista technology Brachytherapy in conjunction with the administration of
lucentis is the best treatment for AMD.
·
AMD is one of the most serious conditions
that affect the macula (the part of the eye responsible for central vision) and
is the main cause of irreparable blindness in people over 60. If left untreated,
the condition gives rise to a rapid loss of central best vision.
There are currently more than 164,000 people with wet AMD in Spain, and 30,000 new cases are detected every year. These
figures are expected to increase in the coming years as the population ages.
NeoVista has begun a definitive clinical trial called CABERNET (CNV Secondary to AMD Treated with BEta RadiatioN
Epiretinal Therapy) to demonstrate the effectiveness of the NeoVista treatment protocol
compared to the results obtained with anti-VEGF therapy alone. This study will
recruit 495 patients in 40 clinical sites throughout the world, including the
Ocular Microsurgery Institute (IMO) in Barcelona, which will begin its initial treatments in February
2008. The IMOR Foundation and the IMO from Barcelona will be the only Spanish centres treating patients in
this extremely important trial. Dr Borja
Corcostegui and Dr Benjamin Guix Melcior will serve as principle investigators and responsible
of the project.
·
To learn more
about prostate cancer treatment by IGRT,
IMRT and Brachytherapy as best
treatment for cancer listen to some of the interview done to Dr Benjamin Guix Melcior, from the IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain, the best treatment for cancer
abroad, cut and paste over the link:
http://profesional.medicinatv.com/webcast/muestra.asp?idfg=0&idwc=1387
·
The Combined treatment
Image-guided Intensity Modulated Radiotherapy (IG-IMRT) plus Prostate
Brachytherapy has been demonstrated to be the best approach for intermediate
and high risk prostate cancer,
as presented today at the World Congress of genito urinary cancer held at San
Francisco. The research has been carried-out at The IMOR Foundation, Medical Institute for Radiotherapy and Oncology,
from Barcelona, Spain, one of the top place to have the best radiotherapy and brachytherapy abroad,
and has been presented by Professor Dr. Benjamin Guix, MD PhD MBA.
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, has been
invited to participate in the 13th Puerto Rico Breast Cancer Conference, to expose the recent
developments in the treatment of breast cancer and the future perspectives that
are now opened. Professor Dr Benjamin
Guix MD PhD MBA,
Director of The IMOR Foundation, Medical Institute for Radiotherapy and
Oncology, from Barcelona, Spain, will present the experience of The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, in
partial breast irradiation, salvage treatment and breast brachytherapy. The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology, has one the best and longest series of patients
treated with these advanced treatments. The IMOR Foundation is considered one
of the best place to have cancer
treatment abroad and has been awarded twice with the Best ESTRO (European Society for Radiotherapy and Oncology) Award, in
2000 and 2007. At the waterfront of the best treatment for breast cancer.
·
The European
Society for Radiotherapy and Oncology (ESTRO) has awarded The IMOR Foundation,
Medical Institute for Radiotherapy and Oncology at Barcelona (Spain) with the BEST BRACHYTHERAPY AWARD. The price was
given to The IMOR Foundation for their contribution to the development of
conservative treatment for cancer,
mainly prostate cancer. The
treatment with brachytherapy, alone or in combination with external beam
radiotherapy, has been demonstrated to produce the highest rates of cure, while preserving the Quality of Life at the best. The award was offered to Professor Dr Benjamin Guix, MD PhD MBA,
Director of The IMOR Foundation, Medical
Institute for Radiotherapy and Oncology, by the president of GEC-ESTRO, Erik Van Limbergen, at a Gala Dinner
held at Montpellier, during the
Celebration of the Annual ESTRO meeting. The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain, is considered one on the best place to have the treatment of cancer abroad.
·
IMRT-Brachytherapy
Combined treatment offers the best
long-term results in the treatment for intermediate- and high-risk prostate
cancer. The 16-year free-from-relapse survival rate was higher than 90%.
The results has been published in the International Journal of Radiation
Oncology Biology and employed the same protocol used at The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Sapin, since
1.999, said Professor Dr Benjamin Guix. Results are really spectacular with a
survival rate unreached with any other technique, even with surgery. PROSTATe_TRAT
COMB_ENG.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona (Spain), starts treating
patients with Image Guided (IGRT)
Intensity Modulated Radiotherapy (IMRT) IG-IMRT. This is the first centre
employing this technology of southern Europe. The IG-IMRT
program is directed by Professor Dr Benjamin Guix with the
collaboration of Dr Antonio Arellano, Antonio Martinez, Ferran Guedea, Josep
Sole and Manel Algara. IGRT-IMRT is
nowadays the best treatment for cancer, and IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain, is considered to be the best
place to have cancer treatment
abroad. JORNADA_IGRT_IMOR_2006_eng.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona
(Spain), starts treating patients for prostate cancer with Image Guided (IGRT), Intensity Modulated Radiotherapy (IMRT) IG-IMRT,
the best and most precise way of radiotherapy and brachytherapy existing today,
announced Professor Dr Benjamin Guix. This is the
first centre employing this technology of southern Europe, what convert
it in the first option to have the best
radiotherapy abroad. “This is the
most precise and modern way for treating
cancer” stated Professor Benjamin
Guix, and is applied mainly prostate cancer, lung cancer,
head and neck cancer, brain tumors and liver metastases as well as liver
cancer. JORNADA_IGRT_IMOR_2006_eng.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Spain has begun the Image Guided Radiotherapy (IGRT), for
the first time in Spain, and southern Europe, announced its
director Professor Benjamin Guix. This is the
best way for treating tumors nowadays, mainly for prostate cancer, lung cancer,
head and neck cancer, brain tumors, breast cancer and liver metastases or
primary tumors, among others. The IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, is one
of the best places to have cancer treatment abroad. IGRT_IMOR_2005_ENG.htm
·
Combined treatment with 3D- conformal Radiotherapy/ IGRT IMRT + Brachytherapy either with I-125
permanent implant or HDR temporal implant, is associated with excellent 3- and 5- year disease-free
survival rates in patients with clinically localized prostate cancer and high PSA levels. Data has been
presented by Dr Benjamin Guix at the ASTRO
(American Society for Radiotherapy and Oncology) meeting. At the same meeting,
Dr Benjamin Guix and Dra Teresa Maria Lacorte, from
The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, presented the
results obtained at IMOR Foundation with combined treatment, with a 8-year cure
rate >95% and with wxcellent Quality of life. These studies confirm Combined
treatment as the best treatment for prostate cancer. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, offers the best
option to have cancer treatment
abroad, with the highest quality.PROSTATe_COMBINED_TREAT_2005.htm
·
Dr Benjamin Guix, Director of the IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain, has presented in the World
Brachytherapy Congress the long-term results of prostate brachytherapy for low-
intermediate- and high-risk prostate cancer. Results are really spectacular,
with extremely high disease-free survival and excellent quality of life. This
is the best treatment for prostate
cancer.
·
Dr Benjamin Guix, Director of the IMOR Foundation presents the European
experience in prostate brachytherapy during the World Congress of
Brachytherapy, the best meeting of radiotherapy and brachytherapy.
·
Gynaecological
Brachytherapy considered as the standard
treatment for the best treatment for
gynaecologycal cancer, informed Dr Jose Antonio Lejarcegui and Professor Dr
Benjamin Guix, Director of The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain. IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain, has the best team with the highest
technology to have cancer treatment
abroad GINE1-ct.htm
·
Prostate
Brachytherapy, increases local control at the same time that decreases side-effects
in prostate cancer, as shown by a multi-center study, in which the contribution
of Doctors from The IMOR Foundation,
Medical Institute for Radiotherapy and Oncology from Barcelona, Sapin, has been very
important, that has been presented by Professor Dr Benjamin Guix, Director of
the IMOR Foundation at the ASCO 2005
ANNUAL MEETING (American Society for Clinical Oncology), held at Chicago
(USA). This treatment offers the best
disease-free survival and the best quality of life for prostate cancer.
·
Brachytherapy-only,
is
a highly effective treatment for breast recurrences. This data have been
confirmed by a trial conducted by scientifics from The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Spain, presented by
Professor Dr Benjamin Guix, at the GEC-ESTRO European Meeting on Brachytherapy,
held at Lubeck (Germany), considered
the best brachytherapy meeting. Brachytherapy is the most effective treatment for cancer.
·
Brachytherapy
offers more than 90 % local control in cancer. Professor Alain Gerbaulet,
former Head of the Brachytherapy Unit from Institute Gustav-Roussy, made this
assertion in the II International
Oncological Meeting, invited by Professor Dr Benjamin Guix Director of the
IMOR Foundation. Nowadays, brachytherapy offers the best results for cancer treatment. The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, offers the
highest technology and the most
experienced team for treating cancer
abroad in southern Europe.
·
The last 8th of april, IMOR Foundation, Medical Insitute for Radiotherapy and Oncology,
held the Ist International Conference
about Advances on Brachytherapy. World leaders in this effective and useful
form of cancer treatment discussed about the recent developments and
discoveries and the state of the art of this extraordinary technique. The
Conference was presided by the catalan minister of Health and Social Security
Mr. Xavier Pomés. By the IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, presented their results Drs Antonio Arellano,
Ferran Guedea and Professor Dr Benjamin Guix and the
physicist Jose Ignacio Tello, about the best
radiotherapy treatment.
·
Brachytherapy
boost useful in early breast cancer. Stage I and II breast
tumors that are treated by a brachytherapy boost are doing better than those
patients without boost even if they have poor prognostic factors as positive
margins, extensive intraductal component or vascular invasion, according to a
consensus meeting held in Barcelona. Results
confirm the IMOR Foundation long-term experience, presented by Professor Dr Benjamin Guix and Jose
Antonio Lejarcegui. The results confirm the
boost as the best option of treatment for breast cancer. This data confirms
The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain,long-term
experience for breast cancer treatment
abroad. Brachytherapy boost in early breast cancer.
·
Local relapses
after conservative treatment for breast cancer, can be safely managed without
mastectomy by means of brachytherapy-only, as a phase II study
presented by Professor Dr Benjamin Guix Director of the
IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, at the ASCO meeting has demonstrated. The brachytherapy is the best treatment for breast cancer
recurrences. Trat_recidivas_mama_CAST.htm
·
Temporary PSA bounces has no significant
prognostic importance, as confirmed by a paper published in the International
Journal of Radiation Oncology Biology and Physics, Dr Benjamin Guix Melcior
explained recently. The study confirms brachytherapy,
alone or in combination with IGRT-IMRT in selected cases, as the best treatment for prostate cancer.
The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, has the longest and highest experience in prostate cancer treatment in souther Europe, with more than 1,000 cases treated, and is the best option for cancer treatment
abroad. PSA SPIKES_ANG.htm
·
Partial Breast
Irradiation (PBI) by Brachytherapy-only very effective treatment for early
stage breast cancer. Differents reports appeared in the Journal of
Clinical Oncology confirm that PBI is a very effective treatment for selected cases of low-risk
small-size breast cancer, professor Dr Benjamin Guix, Director of
the IMOR Foundation, Medical Institute for Radiotherapy and Oncology from
Barcelona, Spain,, reported recently. The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain, has the world series with longer
follow-up of partial breast irradiation, with the state of the art technology and best team. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, is the best
option to have breast cancer treatment abroad. BREAST_BRACHYTHERAPY_ONLY.htm
·
Contents about Professor
Dr Benjamin Guix Melcior, in the
best selection, Director of The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain,
·
:
La braquiterapia
como tratamiento exclusivo en pacientes con cáncer de mama de bajo
riesgo
La Braquiterapia como único tratamiento tras cirugía
conservadora en los casos precoces de cáncer de mama, está
demostrando ser tan efectiva como la radioterapia de toda la mama. Un reciente trabajo
aparecido en la revista Internacional Journal of Radiation Oncology Biology
Physics (IJROBP 2003 55:289-293), publicado por el conjunto de investigadores
de Estados Unidos que trabajan desde hace años en la irradiación
parcial de la mama, refiere que la braquiterapia exclusiva tras
tumorectomía es un tratamiento seguro, con pocos efectos secundarios y
pocas complicaciones y que ofrece unos resultados (al menos a corto plazo)
similares a los obtenidos con radioterapia a toda la mama. Las principales ventajas
de la técnica están relacionadas fundamentalmente con el
acortamiento de la duración total del tratamiento, que sería de 5
días en vez de las 5 semanas y media que normalmente dura. En un primer
momento, el tratamiento está limitado a las pacientes con tumores de
riesgo bajo, esto es tumores de hasta 2 cm de diámetro, sin ganglios
axilares positivos, menopáusicas y cuyos tumores presenten receptores
hormonales positivos.
En el mismo acto de la intervención en la cual se extirpa
el tumor mamario, se coloca en el interior de la cavidad el aplicador de
braquiterapia. Al cabo de 3 días se realiza un TAC para la
dosimetría y se inicia el tratamiento, que tiene una duración de
5 días y se realiza de forma totalmente ambulatoria. Una vez acabado el
tratamiento se retira el aplicador sin necesidad de anestesia,
iniciándose los controles periódicos habituales.
Los efectos secundarios que se observan en algunos casos se
reducen a un enrojecimiento de la piel situada sobre la cavidad tratada.
La Fundación IMOR, es el centro pionero en España y
Europa en estos tipos de tratamiento. Iniciados en 1990, hasta la fecha han
sido tratadas más de 100 pacientes, siendo los resultados obtenidos muy
favorables y sin complicaciones tardías relevantes. Los resultados han sido
presentados por el Profesor Benjamín Guix, Director de la
Fundación IMOR, Instituto Médico de Onco-Radioterapia, en
mútiples foros internacionales, especialmente el Congreso de ASTRO
(Sociedad Americana de Radioterapia) y de ASCO (Sociedad Americana de
Oncología Clínica). El Dr Benjamin Guix, ha destacado en
todos dichos foros la ausencia de complicaciones a largo plazo y el hecho de
que 14 de cada 15 pacientes siguen conservado su mama en perfectas condiciones
más de 15 años después de la recaida. El Dr Benjamin Guix, explica que la
base de estos buenos resultados radica en una cuidadosa selección de las
pacientes tributarias del tratamiento y en una depurada técnica.
“Es realmente maravilloso”, declaró Benjamin Guix “el hecho de
que sigas viendo a las pacientes 15 años después del tratamiento
en perfectas condiciones y preservando su mama. Esto anima mucho a las
pacientes y, evidentemente a los médicos”, concluyó el
prof. Benjamin Guix.
Links de interés sobre el Dr. Benjamin Guix:
Pagina web de Fundación IMOR: www.imor.org
CV abreviado del Dr Benjamin
Guix: www.sanestconsultores.com/uploads/Dr_Benjam_n_Guix_Cv.doc
Presentacion del Dr Benjamin
Guix en la 13th Puerto Rico Breasr cancer
conference: www.acro.org/pdf/BCConference13-bro-w3.pdf
Página de noticias a cargo del Dr. Benjamin Guix www.imor.org/noticias/contenidos3_cast
Presentacion del Dr Benjamin
Guix en la conferencia anual de ASCO www.asco.org/ASCO/Abstarcts+&+virtual+Meeting/Speaker?&spk=Guix%2C+Benjamin+%
Reseña de la presentacion de la braquiterapia transperineal
para el tratamiento del cancer de próstata efectuada por el Dr Benjamin Guix, aparecida en
Diario Medico: http://212.80.128.9/oncologia/n140900bis.html
Otras presentaciones a cargo del Dr. Benjamin Guix
http://profesional.medicinatv.com/webcast/muestra.asp?idfg=0&idwc=1387
http://www.sanestconsultores.com/uploads/Dr_Benjam_n_Guix_CV.doc
http://gucancers.asco.org/portal/site/ASCO/menuitem.34d60f5624ba07fd506fe310ee37a01d/?vgnextoid=76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview=abst_detail_view&confID=10&abstractID=1888
·
IMOR Foundation web site www.imor.org,
·
Benjamin Guix MD PhD MBA home page,
Director of the IMOR Foundation web page
www.telefonica.net/web2/benjaminguix
www.telefonica.net/web2/bguix
www.telefonica.net/web2/b_guix
www.telefonica.net/web2/braquiterapia
www.telefonica.net/web2/brachytherapy
www.telefonica.net/web2/imrt www.telefonica.net/web2/cancerprostata
·
